Cargando…

Programmed Death Ligand-1 Testing in Adenocarcinoma Lung: A Comparative Study of Cell Block versus Biopsy

BACKGROUND: Immunotherapy currently stands as a novel treatment option, specifically in cases of advanced non-small cell lung carcinoma (NSCLC). Expression of programmed death ligand-1 (PD-L1) in tumor cells forms the mainstay for the use of anti-PD-L1 monoclonal antibodies in the treatment of NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shukla, Saumya, Pandey, Rahul K., Gupta, Vani, Husain, Nuzhat, Gupta, Anurag, Kant, Surya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697314/ http://dx.doi.org/10.4103/joc.joc_33_22

Ejemplares similares

A Comparative Study of Cell Block versus Biopsy for Detection of Epidermal Growth Factor Receptor Mutations and Anaplastic Lymphoma Kinase Rearrangement in Adenocarcinoma Lung
por: Gupta, Vani, et al.
Publicado: (2019)

Correlation between Programmed Death Ligand-1 (PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype
por: Pandey, Rahul Kumar, et al.
Publicado: (2022)

Cytomorphological Features of Lung Adenocarcinoma with Anaplastic Lymphoma Kinase Gene Rearrangement
por: Shukla, Saumya, et al.
Publicado: (2019)

The utility of cytology in the diagnosis of adenocarcinoma lung: A tertiary care center study
por: Shukla, Saumya, et al.
Publicado: (2015)

Kirsten rat sarcoma virus protein overexpression in adenocarcinoma lung: Association with clinicopathological and histomorphological features
por: Pandey, Rahul Kumar, et al.
Publicado: (2020)

Comparison of laboratory-developed test & validated assay of programmed death ligand-1 immunohistochemistry in non-small-cell lung carcinoma
por: Nambirajan, Aruna, et al.
Publicado: (2019)

Diagnostic Efficacy of BRAFV600E Immunocytochemistry in Thyroid Aspirates in Bethesda Category IV and Papillary Thyroid Carcinoma
por: Anand, Nidhi, et al.
Publicado: (2021)

Penile neurilemmoma: Utility of fine-needle aspiration cytology in diagnosis of a rare entity
por: Malhotra, Kiran Preet, et al.
Publicado: (2014)

Primary Renal Neuroendocrine Tumour Presenting as an Enormous Cystic Lesion
por: Neyaz, Azfar, et al.
Publicado: (2020)

An intra-thoracic follicular carcinoma of thyroid: An uncommon presentation
por: Kant, Surya, et al.
Publicado: (2017)

Increased Copy Number of Anaplastic Lymphoma Kinase Gene Signal in Lung Carcinomas: Is it Significant?
por: Shukla, Saumya, et al.
Publicado: (2019)

Cytomorphology of pituitary carcinoma metastatic to liver diagnosed by fine-needle aspiration: A rare case report and review of literature
por: Srivastava, Pallavi, et al.
Publicado: (2022)

Scar Endometriosis: Cytological Diagnosis
por: Dwivedi, Urvashee, et al.
Publicado: (2018)

The significance of programmed cell death ligand 1 expression in resected lung adenocarcinoma
por: Wu, Shafei, et al.
Publicado: (2017)

Clinical characteristics and programmed cell death ligand-1 expression in adenocarcinoma in situ and minimally invasive adenocarcinoma of lung
por: Yu, Renke, et al.
Publicado: (2017)

Interactions between programmed death-1 and programmed death ligand-1 promote tolerance by blocking the T cell receptor-induced stop signal
por: Fife, Brian T., et al.
Publicado: (2009)

Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
por: Yu, Wei-Bo, et al.
Publicado: (2019)

Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma
por: Song, Zhengbo, et al.
Publicado: (2016)

Correlation between Programmed Death-1 Ligand-1 and p53 in Patients with Lung Adenocarcinoma
por: Xu, Cheng, et al.
Publicado: (2018)

Altered status of programmed death-ligand 1 after recurrence in resected lung adenocarcinoma patients
por: Chen, Jun, et al.
Publicado: (2017)

Clinicopathological characteristics correlated with programmed cell death-ligand 1 expression in advanced lung adenocarcinoma
por: Gao, Hengxing, et al.
Publicado: (2023)

Distinct prognostic values of programmed death-ligand 1 and programmed cell death protein 1 in lung adenocarcinoma and squamous cell carcinoma patients
por: Wang, Shuo, et al.
Publicado: (2021)

Programmed Death-Ligand 1-Positive Squamous Cell Carcinoma Spontaneously Regressed after Percutaneous Needle Biopsy
por: Sasahara, Masayuki, et al.
Publicado: (2023)

Esthesioneuroblastoma chemotherapy and radiotherapy for extensive disease: a case report
por: Gupta, Seema, et al.
Publicado: (2011)

Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers
por: Liang, Sheng-Kai, et al.
Publicado: (2021)

Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases
por: Liu, Drolaiz H. W., et al.
Publicado: (2023)

Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment
por: Hoshimoto, Aitoshi, et al.
Publicado: (2023)

The Anti-Tumor and Immunomodulatory Effects of PLGA-Based Docetaxel Nanoparticles in Lung Cancer: The Potential Involvement of Necroptotic Cell Death through Reactive Oxygen Species and Calcium Build-Up
por: Gupta, Parul, et al.
Publicado: (2022)

Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma
por: Zhang, Yang, et al.
Publicado: (2014)

Curious case of primary pulmonary mucoepidermoid carcinoma
por: Bajpai, Jyoti, et al.
Publicado: (2019)

Programmed death‐ligand 1 expression in swine chronic infections and enhancement of interleukin‐2 production via programmed death‐1/programmed death‐ligand 1 blockade
por: Ganbaatar, Otgontuya, et al.
Publicado: (2021)

POLE Score: a comprehensive profiling of programmed death 1 ligand 1 expression in pancreatic ductal adenocarcinoma
por: Rahn, Sascha, et al.
Publicado: (2019)

Infiltration of tumor‐associated macrophages is involved in tumor programmed death‐ligand 1 expression in early lung adenocarcinoma
por: Shima, Toshiyuki, et al.
Publicado: (2020)

Ezrin Modulates the Cell Surface Expression of Programmed Cell Death Ligand-1 in Human Cervical Adenocarcinoma Cells
por: Tanaka, Chihiro, et al.
Publicado: (2021)

Comparison of programmed death ligand 1 immunostaining for pancreatic ductal adenocarcinoma between paired cytological and surgical samples
por: Muggilli, Michael, et al.
Publicado: (2021)

Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma
por: Gao, Yuan, et al.
Publicado: (2017)

The Utility of Ancillary Techniques in the Cyto-Diagnosis of Malignant Scalp Lesions
por: Shukla, Saumya, et al.
Publicado: (2021)

Expression of Programmed Cell Death-1 (PD-1) and Its Ligand (PD-L1) in Breast Cancers and Its Association with Clinicopathological Parameters
por: Mehan, Anoushika, et al.
Publicado: (2021)

Tumor-Stroma Ratio and Programmed Cell Death Ligand 1 Expression in Preoperative Biopsy and Matched Laryngeal Carcinoma Surgical Specimen
por: Alessandrini, Lara, et al.
Publicado: (2022)

Cell‐blocks are suitable material for programmed cell death ligand‐1 immunohistochemistry: Comparison of cell‐blocks and matched surgical resection specimens in lung cancer
por: Pak, Min Gyoung, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2f4p4mq212288f4oor3m90keba